Reactive oxygen species released by human blood neutrophils piroxicam-treated healthy subjects.
Damon
M
M
INSERM U 58, Montpellier, France.
Chavis
C
C
Le Doucen
C
C
Blotman
F
F
Crastes de Paulet
A
A
D000328:Adult; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D005609:Free Radicals; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism; D007975:Leukotriene B4 / Q000378:metabolism; D008163:Luminescent Measurements; D008165:Luminol; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D010894:Piroxicam / Q000494:pharmacology*
D001095:Arachidonic Acids; D005609:Free Radicals; D006893:Hydroxyeicosatetraenoic Acids; D010894:Piroxicam; D007975:Leukotriene B4; D016718:Arachidonic Acid; C022022:5-hydroxy-6,8,11,14-eicosatetraenoic acid; D008165:Luminol